ATC Group: A02BC02 Pantoprazole

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A02BC02 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Drugs for acid related disorders
3
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
4
Proton pump inhibitors
5
A02BC02
Pantoprazole

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
40 mg
PAREN - Parenteral
40 mg

Active ingredients in A02BC02

Active Ingredient
Description

Pantoprazole is a substituted benzimidazole which inhibits the secretion of hydrochloric acid in the stomach by specific blockade of the proton pumps of the parietal cells.

Related product monographs

Title
Information Source
Document Type
 
Health Products Regulatory Authority (IE)
Summary of Product Characteristics (SPC)
Health Products Regulatory Authority (IE)
Summary of Product Characteristics (SPC)
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
Health Products and Food Branch (CA)
Structured Product Monograph (SPM)
Health Products Regulatory Authority (ZA)
Medication Package Insert (MPI)

Medicines in this ATC group

Australia (AU)

Canada (CA)

Finland (FI)

France (FR)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Tunisia (TN)

United Kingdom (UK)

While we strive to include the brand names of medicines across all countries, our index remains incomplete. Therefore, it is possible that this medicine may also be marketed under different names in other countries.